Because the expression of GSK-3 is significantly higher in ovarian carcinoma tissues [43], the significant reduction in GSK-3α and β expression in the current study after treatment with genistein indicates an anticancer effect. This evidence concerns the gene GSK3A and ovarian carcinoma.